Study · verified by the research team

Ashwagandha-induced liver injury — A case series from India and literature review

Philips CA, Valsan A, Theruvath AH, et al. (Liver Research Club India) · 2023 · Hepatology Communications 7(10): e0270

https://doi.org/10.1097/HC9.0000000000000270

Indian case series of single-ingredient ashwagandha liver injury, including deaths in patients with pre-existing liver disease.

Study details

DesignCase series + literature review
Population8 patients with single-ingredient ashwagandha HILI (of 23 ashwagandha cases, 2019–2022)
OutcomeLiver injury and outcome
FindingMostly cholestatic hepatitis; 3 patients with underlying chronic liver disease developed acute-on-chronic liver failure and died; products free of contaminants
LimitationsSingle centre network; case series
Certaintylow

Cited by (2)

Chapters (1)

Atlas entrys (1)